Celldex Provides Corporate Update and Reports Fourth Quarter and Year End 2020 Results

Retrieved on: 2021-03-29 19:52:30

Tags for this article:

Click the tags to see associated articles and topics

Celldex Provides Corporate Update and Reports Fourth Quarter and Year End 2020 Results. View article details on hiswai:

Excerpt

CDX-0159—a humanized monoclonal antibody developed by Celldex that binds the KIT receptor with high specificity and potently inhibits its activity.

Article found on: www.biospace.com